Elicio Therapeutics (ELTX) Enterprise Value (2020 - 2026)
Elicio Therapeutics posted quarterly Enterprise Value of -$14.9 million for Q1 2026, up 21.47% year-on-year from -$12.3 million in Q1 2025, and up 19.47% on a QoQ basis from -$18.6 million in Q4 2025.
Elicio Therapeutics (ELTX) has 7 years of Enterprise Value data on file, last reported at -$14.9 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 21.47% year-over-year to -$14.9 million; the trailing twelve-month figure through Mar 2026 stood at -$14.9 million (up 21.47% YoY), and the FY2025 full-year result was -$18.6 million, up 1.24% from the prior year.
- Enterprise Value for Q1 2026 stood at -$14.9 million, up from -$18.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$598000.0 in Q2 2022 and bottomed at -$73.0 million in Q1 2022.
- The 5-year median for Enterprise Value is -$16.5 million (2023), against an average of -$17.7 million.
- The widest annual swing landed in 2022, when Enterprise Value surged 99.49%; it then slumped 3525.75% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$7.8 million in 2022, then sank by 74.63% to -$13.6 million in 2023, then slumped by 38.04% to -$18.8 million in 2024, then increased by 1.24% to -$18.6 million in 2025, then rose by 19.47% to -$14.9 million in 2026.
- The last three Enterprise Value figures came in at -$14.9 million (Q1 2026), -$18.6 million (Q4 2025), and -$20.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | -14.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.95 Mn |
| Dec 31, 2025 | -18.56 Mn |
| Sep 30, 2025 | -20.61 Mn |
| Jun 30, 2025 | -22.09 Mn |
| Mar 31, 2025 | -19.03 Mn |
| Dec 31, 2024 | -18.80 Mn |
| Sep 30, 2024 | -27.33 Mn |
| Jun 30, 2024 | -3.82 Mn |
| Mar 31, 2024 | -12.55 Mn |
| Dec 31, 2023 | -13.62 Mn |
| Sep 30, 2023 | -16.51 Mn |
| Jun 30, 2023 | -21.68 Mn |
| Mar 31, 2023 | -8.57 Mn |
| Dec 31, 2022 | -7.80 Mn |
| Sep 30, 2022 | -1.84 Mn |
| Jun 30, 2022 | -598,000.00 |
| Mar 31, 2022 | -73.00 Mn |
| Dec 31, 2021 | -88.76 Mn |
| Sep 30, 2021 | -102.70 Mn |
| Jun 30, 2021 | -117.30 Mn |
| Mar 31, 2021 | -130.46 Mn |
| Dec 31, 2020 | -34.61 Mn |